---
title: "Macquarie Sticks to Its Hold Rating for Australian Clinical Labs Ltd (ACL)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296156142.md"
description: "Macquarie analyst maintained a Hold rating on Australian Clinical Labs Ltd today and set a price target of A$2.70.Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Australian Clinical Labs Ltd with a A$2.38 average price target."
datetime: "2026-08-17T23:55:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296156142.md)
  - [en](https://longbridge.com/en/news/296156142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296156142.md)
generator: "portal-rs"
---

# Macquarie Sticks to Its Hold Rating for Australian Clinical Labs Ltd (ACL)

Macquarie analyst maintained a Hold rating on Australian Clinical Labs Ltd today and set a price target of A$2.70.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Australian Clinical Labs Ltd with a A$2.38 average price target.

### Related Stocks

- [ACL.AU](https://longbridge.com/en/quote/ACL.AU.md)
- [MQG.AU](https://longbridge.com/en/quote/MQG.AU.md)

## Related News & Research

- [ACL: Strong FY26 margin and cash flow, with stable outlook and continued shareholder returns](https://longbridge.com/en/news/296033240.md)
- [Australian Clinical Labs Sets Date and Nomination Deadline for 2026 AGM](https://longbridge.com/en/news/295354918.md)
- [Northern Star Resources GAAP EPS of A$0.11, revenue of A$7.62B](https://longbridge.com/en/news/296522899.md)
- [Ord Minnett Sticks to Their Buy Rating for Breville Group  (BVILF)](https://longbridge.com/en/news/296432479.md)
- [UBS Reaffirms Their Hold Rating on Deterra Royalties Ltd (DRR)](https://longbridge.com/en/news/296302077.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**